Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Antibiotics | Incidence of Acute Kidney Injury Correlates with Amikacin Use in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
2025-10-15
【Frontier Express】Acta Pharmacologica Sinica | Bevacizumab induces ferroptosis and enhances CD8+ T cell immune activity in liver cancer through modulation of HAT1 and IL-9
2025-10-15
【Frontier Express】Antibiotics | Study on Treatment Strategies for Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections
2025-10-15
【Frontier Express】Journal of Cachexia, Sarcopenia and Muscle | Skeletal Muscle Loss Affects Survival and Anti-Tumor Immune Cell Levels in Advanced Lung Cancer Patients
2025-10-14
【Frontier Express】Small Methods | Novel High-Sensitivity Technology for Detecting Extracellular Vesicles
2025-10-14
【Frontier Express】Small Methods | A Novel High-Sensitivity Technology for Extracellular Vesicle Detection
2025-10-14
【Frontier Express】Materials Today Bio | Synergistic Regulation of Tumor Immune Microenvironment through PD-L1 Targeting and Epigenetic Inhibitors
2025-10-13